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Introduction
Mg 2+ is the second most abundant intracellular cation required for a plethora of metabolic and signalling networks. Under physiologic conditions, intracellular Mg 2+ concentrations vary between 10 and 20 mM in most mammalian cells (Gunther, 2006; Romani, 2011; Wolf, Torsello, Fasanella, & Cittadini, 2003) . About 15-22% of the total cellular Mg 2+ is in the cytoplasm and the lumen of cell organelles. Free ionized cytosolic Mg 2+ was estimated in the range of 0.5-1 mM (Gunther, 2006; Romani, 2011; . Approximately 50% of the total Mg 2+ is bound to nucleotide triphosphates, primarily ATP (Mg·ATP) . A single ribosome binds > 170 Mg 2+ ions (Schuwirth et al., 2005) , and it was estimated that the entire pool of ribosomes may chelate up to 25% of cellular Mg 2+ (Pontes, Sevostyanova, & Groisman, 2015; . A significant portion of Mg 2+ is associated with DNA and nonribosomal RNA species . Mg 2+ is necessary for the activity of > 800 enzymes (de Baaij, Hoenderop, & Bindels, 2015; . Consequently, insufficient cellular Mg 2+ uptake affects protein synthesis/stability, impairs energy metabolism and inhibits cell growth and proliferation (Patel et al., 2017; Pontes et al., 2015; Rubin, 2007; Schmitz et al., 2003; . Organismal Mg 2+ deprivation contributes to widespread human diseases such as type 2 diabetes, metabolic syndrome, osteoporosis and different types of immune, cardiovascular and neurological disorders (reviewed in (de Baaij et al., 2015; Touyz, 2004) ). Furthermore, it has recently been shown that the cellular Mg 2+ concentration regulates the circadian rhythm (Feeney et al., 2016) , osteogenic differentiation (Zhang et al., 2016a) , synaptic plasticity (Palacios-Prado et al., 2014) and the sleep-wake cycle (Ding et al., 2016) . Reduced Mg 2+ levels in blood (hypomagnesemia) and tissues have been observed in elderly individuals (Barbagallo & Dominguez, 2010; Draper, 1964; Touitou et al., 1987) , lending credence to the theory that errors in Mg 2+ metabolism may contribute to aging (Barbagallo, Belvedere, & Dominguez, 2009) . Despite its critical role in physiology and pathophysiology, our https://doi.org/10.1016/j.pharmthera. 2017.11.003 mechanistic understanding of Mg 2+ homeostasis remains fairly vague.
Whole body Mg 2+ balance is maintained by intestinal intake and renal excretion (de Baaij et al., 2015; Konrad, Schlingmann, & Gudermann, 2004) . Classical physiological experiments with different animal species have identified two Mg 2+ transport systems in the kidney and intestinal epithelium: an active transcellular and a passive paracellular pathway (Dai et al., 2001; Quamme, 2008) . The transcellular route consists of apical Mg 2+ entry, likely mediated by Mg 2+ permeable channels, and a basolateral extrusion step involving putative Na + / Mg 2+ exchangers. It has been suggested that the paracellular pathway is primarily responsible for the bulk of Mg 2+ uptake in the intestine and reabsorption in the kidney, whereas the transcellular route plays a regulatory role in the fine adjustment of organismal Mg 2+ balance. For instance, in the kidney, 10-25% of the filtered Mg 2+ is reabsorbed in the proximal tubule and 50-70% in the thick ascending limb via the paracellular route, whereas only~10% is reabsorbed in the distal convoluted tubule (DCT) solely via transcellular transport. No Mg 2+ uptake has been detected in more distal nephron segments, thus supporting the popular theory that the active transcellular route via the DCT determines the final urinary Mg 2+ content and thereby shapes the whole body balance of this mineral (Dai et al., 2001; Quamme, 2008) .
However, the precise physiological role of the above mechanisms in organismal Mg 2+ homeostasis still awaits rigorous testing in genetically modified animal models. In addition, very little is known as to how the Mg 2+ content is maintained in the inorganic component of bones, the amniotic and cerebrospinal fluid.
A search for genes involved in Mg 2+ homeostasis resulted in a list of 20 putative Mg 2+ transporters/channels (Ferre, Hoenderop, & Bindels, 2011) , and there is evidence to suggest that the kinase-coupled channels TRPM6 and TRPM7 are among the prime candidates . The present manuscript provides an overview of the recent progress made in the mechanistic understanding of the role of TRPM6 and TRPM7 in cellular and organismal Mg 2+ balance. Other functionally relevant aspects of these remarkable proteins have been extensively discussed in a number of recent excellent review articles (Asrar & Aarts, 2013; DhenninDuthille, Gautier, Korichneva, & Ouadid-Ahidouch, 2014; Sun, Sukumaran, Schaar, & Singh, 2015) .
TRPM7
2.1. Gene structure, protein topology and expression pattern of TRPM7
The transient receptor potential cation channel, subfamily M, member 7 (TRPM7; also known as TRP-PLIK, ChaK1, LTRPC7) was independently discovered by several research groups (Nadler et al., 2001; Runnels, Yue, & Clapham, 2001; Ryazanov et al., 1997) . The human TRPM7 gene spans 39 exons on chromosome 15 (15q21.2, NCBI Gene ID 54822) and its full-length mRNA encodes a 1863-amino acid protein. The 5′-leader sequence of TRPM7 mRNA contains two evolutionarily conserved open reading frames that cooperate to control the translation of TRPM7 in a Mg 2+ dependent mode (Nikonorova, Kornakov, Dmitriev, Vassilenko, & Ryazanov, 2014) . TRPM7 orthologs have been identified in all vertebrates including genetic model organisms such as zebrafish (D. rerio) and Xenopus laevis (X. laevis) , but not in invertebrate species (Mederos y Schnitzler, Waring, Gudermann, & Chubanov, 2008) . The TRPM7 protein contains a transmembrane TRP channel segment fused to a cytosolic α-type serine/threonine protein kinase domain (also known as MHCK/EF2 kinase domain). α-kinases are defined as atypical serine/threonine protein kinases characterized by low amino acid sequence homology to conventional protein kinases (Ryazanov, Shestakova, & Natapov, 1988; Ryazanov et al., 1997) . Like in other transient receptor potential (TRP) proteins, the TRPM7 channel segment comprises six transmembrane helixes (Fig. 1A) . A short sequence located between the 5th and 6th helixes of TRPM7 forms a predicted pore helix followed by a pore-forming loop (Fig. 1A) . As postulated for other TRP channels, TRPM7 functions as a tetrameric channel complex implying that the pore loops of four TRPM7 subunits contribute to a common ion selectivity filter.
The long cytosolic N-terminus of TRPM7 is highly conserved among TRPM channels, but shows no significant homology to other proteins. Nevertheless, 3D modelling predicts that the N-terminus of TRPM7 (and TRPM6) folds into a set of ankyrin repeats, which are frequently present in other TRP channels as well . The Cterminus of TRPM7 contains a highly conserved TRP domain, a coiledcoil (CC) domain and an α-kinase substrate domain linked to a Cterminal α-kinase domain (Fig. 1A) . Among known ion channels and protein kinases, TRPM7 and its homologous protein TRPM6 are the only examples of ion channels covalently fused to kinases Chubanov et al., 2004; Nadler et al., 2001; Ryazanov, 2002; Schlingmann, Waldegger, Konrad, Chubanov, & Gudermann, 2007; Schlingmann et al., 2002; Walder et al., 2002) .
Mass-spectrometry analysis of recombinant TRPM7 protein identified dozens of autophosphorylation sites, the majority of which are located in the Ser/Thr-rich α-kinase substrate domain of TRPM7 (Cai, Bai, Nanda, & Runnels, 2017; Matsushita et al., 2005) . The CC and α-kinase regions are currently the only domains of TRPM7 for which X-ray chrystallography data have been obtained (Fujiwara & Minor, 2008b; Yamaguchi, Matsushita, Nairn, & Kuriyan, 2001b et al., 2008) ). A stretch of amino acid residues (EVY in TRPM7) that contribute to the cation 'selectivity filter' are indicated in blue. P1017 in TRPM6 mutated in a HSH patient and the corresponding residue in TRPM7 are shown in red. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
V. Chubanov et al. Pharmacology and Therapeutics 184 (2018) 159-176 TRPM7 kinase domains exist as dimers (Yamaguchi, Matsushita, Nairn, & Kuriyan, 2001a) . Although the kinase domain of TRPM7, like other α-kinases, displays no significant primary sequence homology to conventional protein kinases, the crystal structure revealed that the architecture of TRPM7 kinase is remarkably similar to that of conventional kinases and metabolic enzymes harboring ATP-grasp folds (Yamaguchi et al., 2001a) . In addition, catalytically relevant residues are well conserved between TRPM7 and classical protein kinases (Yamaguchi et al., 2001a) . Structural analysis in conjunction with biochemical approaches revealed that the coiled-coil domain of TRPM7 assembles into a fourstranded antiparallel coiled-coil complex (Fujiwara & Minor, 2008a) . Consequently, the hypothesis was put forward that the coiled-coil domains promote the tetrameric association of TRPM7 channels (Fujiwara & Minor, 2008a ). However, a recent investigation of recombinant zebrafish TRPM7 (zTRPM7) showed that a truncation mutation upstream of the coiled-coil domain results in functional zTRPM7 channels (Jansen et al., 2016) . This finding suggests that the coiled-coil domain is not essential for the assembly of a tetrameric TRPM7 channel complex. Our own results are compatible with the notion that the TRPM7 Nterminus may serve such a role (Chubanov et al., 2004) .
Pioneering investigations employing Northern-blot and RT-PCR approaches demonstrated a ubiquitous expression pattern of TRPM7 in human and mouse tissues or cell lines (Nadler et al., 2001; Runnels et al., 2001 ). Numerous subsequent studies on different species further entertained the notion that TRPM7 transcripts are readily detectable in all tissues and cell lines scrutinized so far. Fig. 2 . Functional characterization of endogenous TRPM7 currents in HAP1 cells (modified from (Chubanov et al., 2016) ). TRPM7-deficient HAP1 cells were generated and studied as described previously (Chubanov et al., 2016 V. Chubanov et al. Pharmacology and Therapeutics 184 (2018) 159-176 2.2. Channel properties of TRPM7 TRPM7 cDNAs from several species have been isolated and functionally characterized using the patch-clamp technique . With few minor exceptions (Jansen et al., 2016) , channel features of TRPM7 orthologues were found to be highly conserved. TRPM7 represents a constitutively active ion channel that is selective for divalent cations including Ca 2+ and Mg 2+ as well as trace cations like Zn 2+ (Krapivinsky, Krapivinsky, Manasian, & Clapham, 2014; Monteilh-Zoller et al., 2003; Nadler et al., 2001; Runnels et al., 2001 ). Due to a robust voltage-dependent permeation block by extracellular divalent ions, TRPM7 currents are very tiny at negative membrane potentials. However, external divalent cations only weakly affect large and outwardly rectifying currents carried by monovalent cations at positive membrane potentials (Kerschbaum, Kozak, & Cahalan, 2003b; Nadler et al., 2001) . Site-directed mutagenesis in the poreforming loop of TRPM7 allowed to defined amino acid residues ( 1047 EVY 1049 in mouse TRPM7 (Fig. 1B) ) that contribute to the 'selectivity filter' of the channel pore Mederos y Schnitzler et al., 2008) . Consequently, it was inferred that negatively charged glutamates (E1047 in mouse TRPM7) from four channel subunits may collectively contribute to a binding site for divalent cations Mederos y Schnitzler et al., 2008) . Remarkably, the E1047Q mutation in TRPM7 (Fig. 1A ) gives rise to a new channel type, which is well permeable to monovalent cations, but impermeable to divalent ions Mederos y Schnitzler et al., 2008) , recapitulating unique characteristics of the genetically related TRPM4 and TRPM5 channels (Hofmann, Chubanov, Gudermann, & Montell, 2003; Kaske et al., 2007) (Fig. 1B) . Another point mutation located in the predicted pore helix (P1040R in mouse TRPM7 (Fig. 1) ) results in a dominantnegative TRPM7 channel subunit , highlighting the critical contribution of the latter segments to the overall make-up of the channel pore. (Demeuse, Penner, & Fleig, 2006; Nadler et al., 2001; Schmitz, Deason, & Perraud, 2007) . Due to this characteristic regulatory mechanism, native TRPM7 currents were referred to magnesium nucleotide-regulated metal ion currents (MagNuM (Hermosura, Monteilh-Zoller, Scharenberg, Penner, & Fleig, 2002; Nadler et al., 2001) ) and magnesium-inhibited cation currents (MIC (Kozak, Kerschbaum, & Cahalan, 2002) ). An example of native TRPM7 currents is shown in Fig. 2 . Subsequently, native TRPM7 currents were detected in a wide variety of primary cells and tumor cell lines as summarized in , further supporting the notion that TRPM7 is a ubiquitously expressed channel. TRPM7 single channel conductance has been determined to be~40 pS (Li, Jiang, & Yue, 2006; Norenberg et al., 2016) . Mechanistically, the impact of Mg 2+ and Mg·ATP on TRPM7 channel regulation remains incompletely understood. A conserved residue K1646 in the kinase domain of mouse TRPM7 forms hydrogenbonding interactions with the α-phosphate group and the adenine ring of ATP in the catalytic site of the kinase moiety (Yamaguchi et al., 2001a) (Fig. 1A) . Biophysical assessment of a 'kinase-dead' point mutation (K1646R) or truncated channel variants lacking the whole kinase domain is in line with the assumption that an intact kinase domain is involved in determining the sensitivity of the TRPM7 channel to Mg
2+
and Mg·ATP, but not absolutely necessary for the latter effect (Demeuse et al., 2006; Schmitz et al., 2003) . Of note, a point mutation of a conserved serine residue in the TRP domain (S1107E in mouse TRPM7 (Fig. 1A) ) creates a constitutively active TRPM7 channel insensitive to intracellular Mg 2+ , indicating that the TRP domain plays a key role in TRPM7 channel regulation (Hofmann et al., 2014) . More recently, biophysical analysis of wild-type and truncated variants of the zebrafish TRPM7 channel revealed that the coiled-coil domain also contributes to the channel's sensitivity to intracellular Mg 2+ and Mg·ATP (Jansen et al., 2016) . There is evidence to show that the effects of Mg 2+ and
Mg·ATP on TRPM7 can be strongly modified by TRPM6 in TRPM6/7 heterotetrameric channel complexes as will be discussed in detail in Section 3.2. Gating of TRPM7 is also controlled by the plasma membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP 2 ) (Runnels, Yue, & Clapham, 2002) . Activation of phospholipase C (PLC)-linked G protein-coupled receptors (GPCR) results in depletion of plasma membrane PIP 2 and inactivation of the TRPM7 channel (Runnels et al., 2002) . Along these lines, it was proposed (Kozak, Matsushita, Nairn, & Cahalan, 2005) that Mg 2+ interacts with and neutralizes negatively charged PIP 2 and that this process may explain the inhibitory effect of cytosolic Mg 2+ on TRPM7 currents. Concordant with the latter concept, neutralization of basic residues within the TRP domain (K1112 and R1115 in mouse TRPM7 (Fig. 1A) ) leads to dysfunctional TRPM7 variants with impaired regulation by PIP 2 (Xie et al., 2011) indicating that the TRP domain may be the structural link to PIP 2 in the plasma membrane. However, yet another study reported that the TRPM7 channel is activated rather than inhibited by agonists of GPCR coupled to PLC (Langeslag, Clark, Moolenaar, van Leeuwen, & Jalink, 2007) . To complicate matters even further, engagement of adenylyl cyclase-coupled GPCR also leads to potentiation of TRPM7 channel activity -an effect mediated by cAMP and protein kinase A (Takezawa et al., 2004) . In addition, the TRPM7 channel was found to be susceptible to a variety of external factors including pH (Jiang, Li, & Yue, 2005) , osmotic gradients (Bessac & Fleig, 2007) , mechanical stretch (Kim et al., 2015; Liu et al., 2015; Numata, Shimizu, & Okada, 2007; Oancea, Wolfe, & Clapham, 2006; Xiao et al., 2015) , polyamines (Kerschbaum, Kozak, & Cahalan, 2003a) , chloride and related halides (Yu, Zhang, Lis, Penner, & Fleig, 2013) . There is evidence to show that TRPM7 does not only reside in the plasma membrane, but also in intracellular membrane compartments. Thus, TRPM7 was found to be enriched in intracellular vesicles in different cell lines (Abiria et al., 2017a) . These vesicles contain high levels of glutathione and -as gleaned from the expression pattern of marker proteins -are distinct from endosomes, lysosomes and other organelles. Accordingly, these vesicles were suggested to represent a novel entity and referred to as M7Vs. When cytosolic concentrations are elevated, M7Vs are able to accumulate Zn 2+ . Reactive oxygen species (ROS) were shown to induce TRPM7-dependent Zn 2+ efflux into the cytosol, whereas reduced glutathione prevents TRPM7-dependent Zn 2+ fluxes.
Collectively, the authors surmised that intracellular TRPM7 channels sense oxidative stress and mediate Zn 2+ release from intracellular storage compartments (Abiria et al., 2017a) . Considering that the experimental activation of TRPM7 in the plasma membrane occurs under highly artificial conditions, i.e. depletion of cells from intracellular Mg 2+ , one may wonder whether hitherto unknown endogenous agonists of TRPM7 channels do exist (Hofmann et al., 2014) . This concept has evolved after screening of small drug-like compounds acting as activators of the TRPM7 channel (Hofmann et al., 2014; Schafer et al., 2016) . Among 20 identified substances, naltriben turned out to be the most potent TRPM7 agonist (Hofmann et al., 2014) . Naltriben reversibly activates the recombinant and native TRPM7 channel without prior depletion of intracellular Mg 2+ and even after PIP 2 degradation in the plasma membrane. These results are compatible with the notion that TRPM7 may also harbor a ligandbinding pocket for a putative endogenous agonist, which may act on the TRPM7 channel in analogy to naltriben. Among known drug-like inhibitors of the TRPM7 channel, NS8593 (Chubanov et al., 2012) , waixenicin A (Zierler et al., 2011a) and FTY720 (Qin et al., 2013) are most frequently used. A more detailed overview of the known drug-like inhibitors and activators of TRPM7 has recently been published elsewhere .
Kinase activity of TRPM7
The functional role of the TRPM7 kinase moiety remains less understood. Pioneering biochemical characterization of TRPM7 revealed that the purified TRPM7 kinase phosphorylates myelin basic protein on serine and threonine residues and, as seen with other kinases, that Mg 2+ or Mn 2+ are required for catalytic activity (Ryazanova, Dorovkov, Ansari, & Ryazanov, 2004) . In analogy to other α-kinases, it is assumed that TRPM7 phosphorylates its substrates at sites located in α-helical regions whereas conventional kinases prefer irregular structures, loops and turns of target proteins (Drennan & Ryazanov, 2004) .
By performing a peptide library screen, a positively charged peptide template, i.e. RKKYRIVWKSIFRRFL, was defined as a high-affinity in vitro substrate of TRPM7 kinase ( (Zhang, King, Dalby, & Ren, 2010) and personal communication with Alexey Ryazanov). Recently, a small organic compound, TG100-115, was introduced as a potent new inhibitor of TRPM7 kinase (Song et al., 2017) . Several groups have independently identified first protein substrates of the TRPM7 kinase. Thus, in vitro TRPM7 phosphorylates TRPM6 (Brandao, Deason-Towne, Zhao, Perraud, & Schmitz, 2014) , annexin A1 , myosin II isoforms , eukaryotic elongation factor-2 kinase (eEF2-k) (Perraud, Zhao, Ryazanov, & Schmitz, 2011) , tropomodulin (Dorovkov, Beznosov, Shah, Kotlianskaia, & Kostiukova, 2008) , phospholipase C gamma 2 (PLCγ2) (Deason-Towne, Perraud, & Schmitz, 2012) and probably stromal interaction molecule 2 (STIM2) (Faouzi, Kilch, Horgen, Fleig, & Penner, 2017) . However, up to now, it still remains unclear whether these proteins are bona fide substrates of the TRPM7 kinase in vivo and what the physiological consequences of these posttranslational modifications are. As mentioned before, TRPM7 kinase autophosphorylates its own serine and threonine residues primarily in the 'substrate' domain and less frequently in other parts of the protein Matsushita et al., 2005) .
At present, our understanding of the functional relationship and the potential interplay between the channel and kinase moieties of the TRPM7 protein is still in its infancy. It is not intuitively clear why the latter two protein moieties are covalently linked with each other. As a surprising new facet of this ill-understood relationship, it has recently been postulated that TRPM7 kinase may function independently from the channel protein. Thus, increased caspase activity results in release of the kinase domain from the channel segment (Desai et al., 2012a) . The proteolytic cleavage of TRPM7 was found to be critical for the potentiation of Fas-induced apoptosis by TRPM7 in T cells (Desai et al., 2012a) . The released cytosolic kinase was reported to subsequently translocate to the cell nucleus (Krapivinsky et al., 2014) , where it is able to phosphorylate histones, thus modulating the chromatin epigenetic landscape (Krapivinsky et al., 2014) likely in a Zn 2+ dependent mode (Abiria et al., 2017a) .
TRPM7 in cellular Mg 2+ metabolism
As mentioned above, the TRPM7 channel is highly permeable to Zn 2+ , Ca 2+ and Mg 2+ , and it has been claimed by various researchers that the influx of these cations is relevant for central physiological processes (Monteilh-Zoller et al., 2003; Nadler et al., 2001; Runnels et al., 2001) . Genetic and pharmacological inactivation showed that TRPM7 activity impacts cell motility (Chen et al., 2010; Clark et al., 2006; Kuras, Yun, Chimote, Neumeier, & Conforti, 2012; Meng et al., 2013; Siddiqui, Lively, Vincent, & Schlichter, 2012; Su et al., 2006; Su et al., 2011; Wei et al., 2009 ), proliferation and cell survival Desai et al., 2012b; Nadler et al., 2001; Sahni & Scharenberg, 2008; Schmitz et al., 2003; Zierler et al., 2011b) , differentiation (Abed, Martineau, & Moreau, 2011; Zhang et al., 2016b; Zhang et al., 2012) Krapivinsky, & Clapham, 2008) , immune responses (Chimote et al., 2013; Kuras et al., 2012; Zierler et al., 2016) , cytoskeletal architecture (Clark, Middelbeek, Dorovkov, et al., 2008; , and Ca 2+ signaling events such as Ca 2+ oscillations (Bernhardt, Padilla-Banks, Stein, Zhang, & Williams, 2017; Carvacho et al., 2016) , store-operated Ca 2+ entry (SOCE) (Faouzi et al., 2017) and Ca 2+ flicker activity (Wei et al., 2009 ). In addition, it has been posited that TRPM7 is involved in anoxic neuronal death (Aarts et al., 2003) , hypertension (Antunes et al., 2016; Touyz, 2008) , neurodegenerative disorders (Hermosura et al., 2005a; Tseveleki et al., 2010) , atrial fibrillation (Du et al., 2010) , cardiac fibrosis (Du et al., 2010) , tumor growth and progression (Chen, Chen, Chiu, & Shen, 2013; Gao et al., 2011; Guilbert et al., 2009; Hanano et al., 2004; Jiang et al., 2007; Kim et al., 2008; Middelbeek et al., 2012; Rybarczyk et al., 2012) , and oxidative stress responses (Abiria et al., 2017b; Xu, Liu, Yuan, & Liu, 2017 ). In the current manuscript, we will overview the recent progress in our understanding of the involvement of TRPM7 in cellular Mg 2+ metabolism. Other functional aspects have been extensively discussed in a number of recent review articles (Asrar & Aarts, 2013; Bae & Sun, 2013; Cabezas-Bratesco et al., 2015; Chubanov et al., 2017; Chubanov, Schafer, Ferioli, & Gudermann, 2014; Dhennin-Duthille et al., 2014; Gautier et al., 2016; Park, Hong, Kim, & So, 2014; Schmitz et al., 2014; Sun et al., 2015; Trapani, Arduini, Cittadini, & Wolf, 2013; Visser, Middelbeek, van Leeuwen, & Jalink, 2014; Xu et al., 2015; Yee, 2017; Yee, Kazi, & Yee, 2014) . Most intracellular Mg 2+ is bound to ATP and other nucleotides, proteins, phospholipids and nucleic acids. As a cell grows and divides, it must double all these components including its Mg 2+ content (Rubin, 2005; Wolf, 2004) . Hence, defective cellular Mg 2+ uptake may limit the ability of cells to proliferate. The latter working hypothesis has been tested using the chicken B lymphocyte cell line DT40 carrying a null mutation in the chicken Trpm7 gene (Schmitz et al., 2003) . DT40 cells allow efficient gene targeting, because of a high level of homologous recombination and a stable phenotype. As expected, DT40 cells lacking TRPM7 were not viable (Schmitz et al., 2003) . However, supplementation of the cell culture medium with high levels of Mg 2+ , but not Ca 2+ , restored the viability of Trpm7-deficient cells (Schmitz et al., 2003) . Expression of wild-type and 'kinase-dead' variants of human TRPM7 rescued the proliferation defect of mutant DT40 cells (Schmitz et al., 2003) . Further experiments showed that the cell cycle of DT40 B lymphocytes lacking TRPM7 was arrested in the G0 phase, accompanied by down-regulation of PI3K-AKT signaling and accumulation of the CDK inhibitor p27kip1 (Sahni & Scharenberg, 2008; Sahni, Tamura, Sweet, & Scharenberg, 2010) . In summary, the authors concluded that the TRPM7 channel is indispensable for Mg 2+ homeostasis in vertebrate cells.
In follow-up studies, DT40 cells lacking TRPM7 were employed to functionally assess new Mg 2+ channels/transporters. Thus, reconstitution of TRPM7-deficient B lymphocytes with SLC41A1, SLC41A2 and MagT1 restored their proliferative capacity (Deason-Towne, Mandt, Song, Scharenberg, & Sahni, 2011; Sahni, Nelson, & Scharenberg, 2007; Sahni, Song, & Scharenberg, 2012) . In contrast, attempts to replace TRPM7 by human TRPM6 were not successful (Schmitz et al., 2005) . Mg 2+ -dependent proliferation arrest emerged as the most prominent phenotype of TRPM7-deficient cells. Thus, independent studies revealed that mouse embryonic stem (ES) and trophoblast stem (TS) cells isolated from Trpm7-gene deficient blastocysts failed to proliferate at physiological Mg 2+ concentrations in the culture medium (Chubanov et al., 2016; Ryazanova et al., 2010a) . The growth arrest of TRPM7-deficient ES and TS cells can be overcome by high extracellular levels of Mg 2+ (Chubanov et al., 2016; Ryazanova et al., 2010a) . Recently, our laboratory has exploited a human haploid leukaemia cell line (HAP1 cells) (Blomen et al., 2015; Essletzbichler et al., 2014; Wang et al., 2015) as a new genetically tractable model to interrogate the cellular role of TRPM7 (Chubanov et al., 2016) . CRISPR/Cas9-mediated ablation of the TRPM7 protein in HAP1 cells completely abolished endogenous TRPM7 currents (Chubanov et al., 2016) (Fig. 2) . When cultured in standard medium, TRPM7-deficient cells displayed a reduced total cellular Mg 2+ content accompanied by a Mg 2+ -dependent proliferation defect (Chubanov et al., 2016) . However, TRPM7-deficient cells proliferated normally in culture medium supplemented with 10 mM Mg 2+ (Chubanov et al., 2016) as exemplified in Fig. 2 . The role of TRPM7 in Mg 2+ homeostasis of non-proliferating, differentiated cells is not well defined yet. In one study, primary isolated rat ventricular myocytes were exposed to TRPM7 inhibitors (NS8593 and 2-APB) and an activator (naltriben) to show that TRPM7 may serve as a major physiological point of entry of Mg 2+ into myocytes.
Finally, experiments with the genetically related TRPM6 protein suggested that its crucial role in organismal Mg 2+ homeostasis requires the assembly of TRPM6 with TRPM7 in heterotetrameric channel complexes. This vital functional aspect of TRPM7 will be further discussed in Section 3.2. To summarize, there is a solid body of evidence to support the notion that TRPM7 is required for cellular Mg 2+ uptake.
TRPM7 in human diseases
The association of single-nucleotide polymorphisms (SNPs) of TRPM7 and several human diseases has been reported. Guamanian amyotrophic lateral sclerosis (ALS-G) and parkinsonism dementia (PD-G) are neurodegenerative disorders that are highly prevalent in the Guam population, most probably because of prolonged exposure to an environment low in Ca 2+ and Mg 2+ and high levels of toxic metals. The T1482I polymorphism in TRPM7 has been shown to associate with ALS-G and PD-G subjects in Guam (Hermosura et al., 2005b) , but not in the Kii population in Japan (Hara et al., 2010) . In another study (Dai et al., 2007) , the T1482I polymorphism was found to be associated with an elevated risk of both adenomatous and hyperplastic polyps. Moreover, the T1482I polymorphism was found to be linked to Ca:Mg intake supporting the notion that TRPM7 dependent intestinal intake of divalent cations is associated with the risk of adenomatous colorectal neoplasia (Dai et al., 2007) . Two other TRPM7 SNPs (rs8042919 and rs7173321) are associated with breast cancer patients in the Han population of China (Shen et al., 2014) . A screen for inherited forms of macrothrombocytopenia in humans resulted in the identification of two pedigrees harbouring point mutations in the human TRPM7 gene (Stritt et al., 2016) . Macrothrombocytopenia (or giant platelet disorder) is characterized by a reduced number of abnormally large platelets and a tendency to bleeding. Platelets are produced from megakaryocytes in the bone marrow and this process (thrombopoiesis) critically relies on an intact cytoskeleton. The newly identified patients were heterozygous for two missense mutations in TRPM7, i.e. C721G and R902C, displayed impaired thrombopoiesis, reduced Mg 2+ and abnormal cytoskeletal architecture of platelets (Stritt et al., 2016) . The C721G and R902C variants are located in the channel segment of TRPM7. Introduction of these missense mutations into the recombinant TRPM7 protein resulted in suppression of TRPM7 currents. Interestingly, megakaryocyte-restricted inactivation of Trpm7 in mice recapitulates the phenotype of the human patients afflicted with the C721G and R902C mutations. In contrast, kinase-dead Trpm7 knock-in (KI) mice show no obvious defect in thrombopoiesis (Stritt et al., 2016) . These findings were interpreted to mean that impaired channel activity of TRPM7 entails Mg 2+ deficiency in megakaryocytes resulting in cytoskeletal alterations and impaired platelet formation in affected individuals (Stritt et al., 2016 
In vivo role of TRPM7 gleaned from animal models
The physiological role of TRPM7 has been extensively studied in genetically tractable animal models including mouse, zebrafish and frog. Three different Trpm7 KO mice were reported. Trpm7 βgeo and Trpm7 Δ17 mutations constitutively disrupt the expression of the TRPM7 protein and, therefore, were defined as null mutations (Jin et al., 2008; Ryazanova et al., 2010a) . The Trpm7 Δkinase allele was generated by constitutive deletion of Trpm7 exons encoding the kinase domain and can also be regarded as a true null mutation, since Trpm7
Δkinase/Δkinase embryonic stem cells are devoid of any TRPM7 currents and are able to proliferate only in culture medium supplemented with Mg 2+ (Ryazanova et al., 2010a) . Mice homozygous for any of the three KO alleles die at embryonic day 6.5-7.5 (e6.5-e7.5) for unknown reasons (Jin et al., 2008; Ryazanova et al., 2010b) . However, Trpm7
Δkinase/+ heterozygous mice are viable and are characterized by reduced Mg 2+ levels in blood, bones and urine (Ryazanova et al., 2010b) . In contrast to controls, a substantial fraction of Trpm7 Δkinase/+ mice die shortly after placing them on a Mg 2+ -deficient diet suggesting that a key aspect of TRPM7 function is the regulation of organismal Mg 2+ homeostasis.
Trpm7
Δkinase/+ mice were further employed to assess the role of TRPM7 in ameloblasts, odontoblasts and osteoblasts, which are responsible for the formation of enamel, dentin and bone, respectively (Nakano et al., 2016) . All the latter tissues were hypomineralized in Trpm7
Δkinase/+ mice, most likely due to impaired alkaline phosphatase (ALPase) activity (Nakano et al., 2016) . Mg 2+ is essential for ALPase activity, and, accordingly, ex vivo Mg 2+ supplementation rescued ALPase activity in
Δkinase/+ tissues, suggesting that the mineralization defect was triggered by Mg 2+ deficiency (Nakano et al., 2016) . In another study, phenotyping of Trpm7 Δkinase/+ mice indicated that TRPM7 plays a role in Ang II-induced hypertension and associated vascular and target organ damage and that these pathological effects are associated with reduced Mg 2+ concentrations in blood and vascular cells (Antunes et al., 2016) . Conditional mutagenesis of a floxed Trpm7 allele (Trpm7 fl ) in mice was used to address the spatiotemporal requirement for Trpm7 during embryonic development. An early epiblast-restricted ablation of Trpm7 resulted in lethality indicating that Trpm7 is required within the embryo proper (Jin et al., 2008) . Global inactivation of Trpm7 at e7-9 also caused embryonic mortality. In contrast, ablation of Trpm7 at e14.5 produced viable and healthy Trpm7 null offspring suggesting that Trpm7 is required only before and during organogenesis (Jin et al., 2008) . Furthermore, global deletion of Trpm7 in 4-or 6-weeks old mice did not result in major pathologic phenotypes. Unfortunately, the authors did not study mineral homeostasis in Trpm7-deficient adult mice. Subsequently, a set of Cre transgenes was used to define the role of TRPM7 in the morphogenesis of several organs. Deletion of Trpm7 in the T-cell lineage disrupted thymopoiesis (Jin et al., 2008) . Trpm7-deficient thymocytes exhibited deregulated production of many growth factors involved in the differentiation and maintenance of thymic epithelial cells (Jin et al., 2008) . In addition, the latter study attempted to assess Mg 2+ balance in Trpm7-deficient thymocytes and T cells. Unexpectedly, the authors found that Mg 2+ uptake and total cellular Mg 2+ content were normal in mutant T cells (Jin et al., 2008) .
TRPM7 was found to be critically involved in kidney morphogenesis (Jin et al., 2012) . Nephrons are derived from the metanephric mesenchyme, whereas collecting ducts develop from the ureteric bud. Inactivation of Trpm7 in the embryonic ureteric bud results in lack of TRPM7 protein in collecting ducts of the postnatal kidney without obvious morphological and functional alterations (Jin et al., 2012) . In contrast, deletion of Trpm7 in the embryonic metanephric mesenchyme entailed absence of TRPM7 protein specifically in renal tubules of adult mice. The latter mutant mice showed morphological alterations of the kidney including a reduction of the number of glomeruli, renal tubular dilation and formation of cysts in proximal tubules. Hence, Trpm7 function in the metanephric mesenchyme is required for nephrogenesis V. Chubanov et al. Pharmacology and Therapeutics 184 (2018) 159-176 (Jin et al., 2012) . Inactivation of Trpm7 in neural crest cells at e10.5 results in loss of dorsal root ganglion neurons and skin melanocytes (Jin et al., 2012) . In addition, primary mouse embryonic fibroblasts (MEFs) were used to generate induced pluripotent stem (iPS) cells and, subsequently, to differentiate these iPS cells to neural crest (NC) cells with disrupted Trpm7 (Jin et al., 2012) . Most remarkably, Trpm7-deficient NC cells showed normal cellular Mg 2+ content, unimpaired self-renewal and ability to differentiate into neurons (Jin et al., 2012) . Cardiac deletion of Trpm7 at e9.0 results in heart failure and death (Sah, Mesirca, Mason, et al., 2013) . However, ablation of cardiac Trpm7 at e13.0 gives rise to viable mice with normal heart function, whereas deletion of Trpm7 at an intermediate time-point reduces the viability of mutants to 50%. Surviving mutant mice display cardiomyopathy associated with heart block, impaired repolarization and ventricular arrhythmias (Sah, Mesirca, Mason, et al., 2013) . Finally, inactivation of Trpm7 specifically in the embryonic myocardium or the sinoatrial node revealed a key role of TRPM7 in cardiac automaticity, probably due a down-regulation of Hcn4 expression and, consequently, reduction of the hyperpolarization-activated (I f ) current in pacemaker cells of the sinoatrial node (Sah, Mesirca, Van den Boogert, et al., 2013) . To summarize, conditional inactivation of Trpm7 in mice showed that TRPM7 plays a critical role in early embryonic development and morphogenesis of internal organs. The exact molecular mechanisms underlying such crucial prenatal requirements of Trpm7 still remain to be defined. Yet, cell type specific deletions of Trpm7 cast serious doubts on the concept that all TRPM7 phenotypes can be comprehensively explained by Mg 2+ deficiency.
In contrast to Trpm7 null mutations, specific inactivation of TRPM7 α-kinase activity is neither detrimental to embryonic development nor postnatal survival of mice (Kaitsuka et al., 2014) . Thus, mice homozygous for a global constitutive 'kinase-dead' KI point mutation, K1646R, in the catalytic site of the TRPM7 kinase domain (Trpm7 R/R mice) displayed normal prenatal and postnatal survival, unchanged Ca 2+ and Mg 2+ serum levels and did not exhibit obvious pathologic phenotypes consistent with the notion that the embryonic Trpm7 null phenotypes are primarily caused by impaired channel activity of TRPM7 (Kaitsuka et al., 2014) . In an independent study, adult Trpm7 R/R mice were found to be more resistant to dietary Mg 2+ deprivation in terms of survival and development of systemic Mg 2+ deficiency (Ryazanova et al., 2014) . These latter observations are consistent with the conjecture that the TRPM7 kinase moiety may function as a sensor of the organismal Mg 2+ status (Ryazanova et al., 2014) .
The in vivo role of TRPM7 has been also assessed in non-mammalian model organisms like zebrafish and X. leavis. Several loss-of-function mutations in zebrafish Trpm7 (zTrpm7) have been identified (Elizondo et al., 2005; Elizondo, Budi, & Parichy, 2010; Low et al., 2011; McNeill et al., 2007; Sah, Mesirca, Van den Boogert, et al., 2013; Yee, Zhou, & Liang, 2011) . zTrpm7 is broadly expressed in embryos and larvae with highest levels in the pronephric and mesonephric kidneys, and in the corpuscles of Stannius (CS), a gland that regulates ion homeostasis in fish. zTrpm7-deficient fish showed normal morphogenesis in early embryos. However, mutant larvae developed multiple abnormalities including impaired touch responsiveness, defective melanin synthesis and apoptotic death of melanophores, defective proliferation of epithelial cells in the exocrine pancreas, disturbed cardiac automaticity and mortality at late larval time points (Elizondo et al., 2005; Elizondo et al., 2010; Low et al., 2011; McNeill et al., 2007; Sah, Mesirca, Van den Boogert, et al., 2013; Yee et al., 2011) . Trpm7 mutant larvae show reduced organismal levels of Mg 2+ and Ca 2+ (Elizondo et al., 2010; Yee et al., 2011) . Mg 2+ , but not Ca 2+ supplementation partially rescues melanophore survival and proliferation of cells in the exocrine pancreas (Elizondo et al., 2010; Yee et al., 2011) . Trpm7 mutants develop kidney stones, and express increased levels of CS-derived hormones stanniocalcin 1 (STC1) and fibroblast growth factor 23 (FGF23) (Elizondo et al., 2010) . STC1 is an established regulator of Ca 2+ homeostasis (Yeung, Law, & Wong, 2012) , whereas FGF23 is known as a potent antihyperphosphatemic factor (Haussler et al., 2012) . The concentrations of Mg 2+ and Ca 2+ can be normalized in zTrpm7 mutants by suppression of STC1 activity, whereas the formation of kidney stones can be prevented by knock-down of FGF23 (Elizondo et al., 2010) . Hence, zTrpm7 assumes a central role in Mg 2+ and Ca 2+ homeostasis in conjunction with STC1 and FGF23. TRPM7 is also critically involved in embryonic development of X. leavis. Knock-down of Xenopus Trpm7 (xTrpm7) using morpholino oligonucleotides reveals that the xTrpm7 controls Rac-dependent polarized cell movements and that down-regulation of xTrpm7 leads to impaired gastrulation . The gastrulation defect could be rescued by Mg 2+ supplementation and by overexpression of the Mg 2+ transporter SLC41A2. Therefore, the xTrpm7 gastrulation phenotype in X. leavis is most likely triggered by abnormal Mg 2+ homeostasis in embryonic cells . Taken together, the experiments with different animal species support the concept that TRPM7 is essential for early embryonic development and organogenesis and that TRPM7 orchestrates tissue Mg 2+ homeostasis. However, the differential contribution of channel and kinase activity of TRPM7 to Mg 2+ balance is still a moot issue.
TRPM6
3.1. Gene structure, protein topology and expression patterns of TRPM6 TRPM6 orthologs were found in all vertebrate species. The human TRPM6 gene is located on chromosome 9 (9q21.13) and comprises 39 exons. Multiple alternatively spliced mRNA isoforms are derived from the human gene. Three alternative 5′ exons (exon 1A, 1B and 1C) of the gene can be spliced to a common second exon resulting in three fulllength mRNA variants, TRPM6a, TRPM6b and TRPM6c (Chubanov et al., 2004) . In addition, several alternatively spliced transcripts lacking exons coding for the channel segment have been identified. These splice variants were named M6-kinases 1, 2 and 3 (Chubanov et al., 2004) . So far, the TRPM6a cDNA variant has been extensively used for heterologous expression studies, whereas the functional properties of the other TRPM6 gene products still remain unknown.
The human TRPM6a variant encodes a large 2022 amino acid protein. The overall protein architecture of TRPM6 is similar to that of TRPM7 (Fig. 1) . Specific overexpression strategies (for details see below) allowed hTRPM6a to assemble into functional homotetrameric TRPM6 and heterotetrameric TRPM6/7 channel complexes. Co-expression of wild-type TRPM7 with a TRPM6 variant carrying a dominant negative point mutation in its pore-forming region (P1017R) resulted in suppression of TRPM7 currents indicating that the transmembrane segments of TRPM6 and TRPM7 associate to form a common channel pore . Another mutation, S141L in the intracellular N-terminus of human TRPM6 (S138L in mouse TRPM7), disrupts tetrameric channel assembly underscoring the critical role of the N-terminus for the formation of functional channel complexes (Chubanov et al., 2004) . In addition, it was suggested that the coiled coil domains of TRPM7 and TRPM6 are directly involved in the assembly of tetrameric channel-kinase complexes (Fujiwara & Minor, 2008a) . Structural and biochemical experiments revealed that the kinase domains of TRPM6 and TRPM7 form homo-and heterodimers, and that such dimerization is required for kinase activity (Crawley & Cote, 2009; Fujiwara & Minor, 2008a) . Finally, a dimerization motif (amino acids 1700-1730 in human TRPM6a) was identified as the determinant of TRPM6 kinase dimer formation (van der Wijst et al., 2014) . Mutagenesis of critical residues in this domain blocked kinase activity and negatively impacted channel activity (van der Wijst et al., 2014) . Early TRPM6 expression profiling by Northern blot and RT-PCR indicated that TRPM6 expression is limited to the intestine, kidney and testis (Schlingmann et al., 2002; Walder et al., 2002) . RT-PCR analysis V. Chubanov et al. Pharmacology and Therapeutics 184 (2018) [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] of microdissected rat nephrons revealed high expression levels of TRPM6 in the distal convoluted tubule (DCT) and low levels in the proximal tubule and collecting duct (Schlingmann et al., 2002) . Immunolocalization of mouse TRPM6 using a polyclonal TRPM6-specific antibody visualized the protein at the apical surface of DCT cells in the kidney (Voets et al., 2004) , and in the brush-border of epithelial cells in the duodenum (Voets et al., 2004 (Jang et al., 2012) and placental trophoblasts (Suzuki, Watanabe, Saito, & Tominaga, 2017) . In addition, TRPM6 is highly expressed in the visceral yolk sac endoderm and in the network of transporting trophoblasts (syncytiotrophoblasts type I) in the placental labyrinth (Chubanov et al., 2016) .
Channel properties of TRPM6
Until recently, the functional assessment of the TRPM6 channel has been restricted to the heterologously expressed human TRPM6a isoform. Our group Chubanov et al., 2004 ) and other investigators (Schmitz et al., 2005; Suzuki et al., 2017) observed that human TRPM6a does not efficiently form homomultimeric channels in the plasma membrane, but requires TRPM7 to be co-targeted to the cell surface Chubanov et al., 2004) . The assembly of heteromeric TRPM6/7 channel complexes was demonstrated by fluorescence resonance energy transfer (FRET) and co-immunoprecipitation as well as by functional analysis of channel subunits carrying a dominant-negative point mutation in the pore-forming segment Chubanov et al., 2004; Schmitz et al., 2005) . Within heteromeric TRPM6/7 channel complexes, human TRPM6a increased the current amplitude of TRPM6/7 heteromers as compared to TRPM7 homomers Chubanov et al., 2004) .
According to other investigators Voets et al., 2004) , overexpressed TRPM6a in the pCINeo-IRES-GFP bicistronic vector (pCINeo-hTRPM6-IRES-GFP expression construct) was able to form homomeric channels with functional characteristics mirroring the TRPM7 channel in many aspects. Thus, human TRPM6a was found to be highly permeable to Mg 2+ or Ca 2+ , and sensitive to pH and PIP 2 levels Voets et al., 2004; Xie et al., 2011) . In addition, currents measured in pCINeo-hTRPM6-IRES-GFP expressing cells were negatively regulated by hydrogen peroxide, 17β-estradiol and sphingosine (Cao et al., 2010; Li et al., 2006; Qin et al., 2012; Voets et al., 2004; Xie et al., 2011) . Furthermore, insulin and EGF acting via Rac1 increased cell surface expression of human TRPM6a (Nair et al., 2012; Thebault et al., 2009 Voets et al., 2004) . In contrast, another laboratory observed that pCINeo-hTRPM6-IRES-GFP evoked currents that were completely insensitive to physiological (3-9 mM) levels of Mg·ATP, whereas Mg 2+ efficiently blocked hTRPM6 currents with a physiologically irrelevant IC 50 of 29 μM . Furthermore, co-expression of human TRPM6a with human TRPM7 resulted in heteromeric channel complexes unresponsive to Mg·ATP and a TRPM7-like response to Mg 2+ . This study also showed that expression of recombinant human TRPM6a gives rise to a functional channel only, if TRPM6a cDNA was inserted into the pCINeo-IRES-GFP vector, whereas the same cDNA sequence placed in other expression plasmids did not yield TRPM6a currents . This feature is very unusual and still lacks any mechanistic explanation. More importantly, it is currently not possible to exclude a potential effect of the pCINeo-IRES-GFP vector on key functional properties of human TRPM6a currents such as sensitivity to cytosolic Mg 2+ and
Mg·ATP.
Since the functional characteristics of heterologously expressed human TRPM6a are surrounded by considerable controversy, the functional analysis of primary cells lacking the endogenous mouse TRPM6 protein may represent a promising alternative option. Given the high expression of TRPM6 in placental trophoblasts, trophoblast stem (TS) cells derived from Trpm6-and Trpm7-gene deficient mouse blastocysts were investigated (Chubanov et al., 2016) . Wildtype TS cells express both TRPM6 and TRPM7, thus reliably reflecting the in vivo situation in transporting epithelial cells invariably co-expressing both proteins. Wildtype TS cells exhibit TRPM6/7-like currents, and genetic elimination of TRPM6 reduces the amplitude of these currents. Ionic currents in mTRPM6-deficient TS cells were substantially more sensitive to Mg·ATP but equally affected by Mg 2+ (Chubanov et al., 2016) .
In contrast, deletion of mTRPM7 resulted in complete disappearance of native TRPM6/7-like currents (Chubanov et al., 2016) . These findings support the concept that native TRPM6 primarily functions as a subunit of heteromeric TRPM6/7 channels and that Mg·ATP most likely is a crucial endogenous regulator of Mg 2+ uptake mediated by TRPM6/7 channels. The experiments with Trpm6-and Trpm7-gene deficient TS cells are consistent with a study by Zhang et al. dissecting the contribution of TRPM6 and TRPM7 to endogenous currents in human neuroblastoma SHEP-21N cells, with work of Ryazanova et al. examining native TRPM6 and TRPM7 currents in mouse embryonic stem (ES) cells (Ryazanova et al., 2010a) , with the studies by Krapivinsky et al. (Abiria et al., 2017b; Krapivinsky et al., 2017) investigating the functions of TRPM6 and TRPM7 in HEK 293 cells and our experiments with HAP1 cells (Chubanov et al., 2016) (Fig. 2) . Although TRPM6 and TRPM7 were co-expressed in the latter cell lines, genetic ablation of TRPM7 was sufficient to fully eliminate all endogenous TRPM6/7-like currents.
Considering that the functional characteristics of human TRPM6a are highly dependent on the expression strategies chosen, full-length mouse TRPM6 was recently isolated, representing an alternative experimental tool that could be expressed by means of different expression constructs . Mouse TRPM6 homomeric channels could be functionally expressed irrespective of the vector backbone used. Although such overexpression systems do not fully mirror the properties of native TRPM6 (as discussed above: Endogenous TRPM6 was active only in the presence of TRPM7 (Chubanov et al., 2016) ), this new in vitro model may be instrumental in dissecting specific functional hallmarks of TRPM6. For instance, overexpression of mouse TRPM6 in HEK 293 cells yielded currents significantly (~3-fold) smaller than mouse TRPM7 currents. In contrast to TRPM7, the mouse TRPM6 channel displayed a fast run-down: TRPM6 currents inactivated rapidly, especially when the TRPM6-expressing cells were exposed to monovalent cation-based external solutions. Unexpectedly, the mouse TRPM6 channel was found to be highly sensitive to cytosolic Mg 2+ . (Chubanov et al., 2016) . Remarkably, TRPM6/7 channels displayed very high channel activity already after break-in of the patch, suggesting that TRPM6/7 complexes are constitutively active in the presence of steady-state cytosolic concentrations of Mg 2+ and Mg·ATP. In line with this assumption and in stark contrast to TRPM7, TRPM6/7
V. Chubanov et al. Pharmacology and Therapeutics 184 (2018) 159-176 currents were only slightly inhibited by physiological levels of Mg·ATP (3-9 mM) and were significantly more active in the presence of physiological Mg 2+ levels (0.5-1 mM).
Experiments with murine native and recombinant TRPM6/7 channels allow to further refine a previously suggested model (Chubanov et al., 2004) for the roles of TRPM6 and TRPM7 in TRPM6/7 heteromers (Fig. 3) (Fig. 3) .
Kinase activity of TRPM6
In vivo substrates of TRPM6 kinase are currently unknown. However, in vitro experiments demonstrated that, similar to TRPM7, TRPM6 kinase can phosphorylate myosin IIA, IIB and IIC (Clark et al., 2006; , suggesting that TRPM7 and TRPM6 kinases may have common phosphorylation target proteins. Recently, it has been reported that, similar to TRPM7, the Cterminal kinase domain of TRPM6 can be cleaved from the channel domain in HEK 293 cells (Krapivinsky et al., 2017) . The cleaved kinase may subsequently translocate to the nucleus and bind to the arginine methyltransferase 5 (PRMT5) protein complex (Krapivinsky et al., 2017) . This interaction enabled the TRPM6 kinase domain to phosphorylate histones H2A and H3 and, consequently, to alter the transcriptome of HEK 293 cells (Krapivinsky et al., 2017) . In future studies, it will be interesting to investigate whether the latter function of TRPM6 kinase in HEK 293 cells has a bearing on the physiological role of TRPM6 in vivo.
In analogy to TRPM7, TRPM6 kinase can auto-phosphorylate its own Ser/Thr residues . Upon co-expression with TRPM7, TRPM6 is able to crossphosphorylate TRPM7 Schmitz et al., 2005) . The kinase domain of TRPM6 can directly interact with the repressor of estrogen receptor activity (REA), the receptor of activated protein kinase C 1 (RACK1) and methionine sulfoxide reductase B1 (MsrB1) (Cao et al., 2010; Cao et al., 2008; Cao et al., 2009 ). Co-expression of recombinant REA, RACK1 and MsrB1 with human TRPM6a cDNA resulted in a moderate suppression of TRPM6 channel activity (Cao et al., 2010; Cao et al., 2008; Cao et al., 2009 ). However, it remains unknown whether TRPM6 kinase phosphorylates REA, RACK1 and MsrB1.
Currently, there are only two synthetic compounds known as inhibitors of TRPM6 kinase. Davis et al. (Davis et al., 2011) evaluated the susceptibility of 442 kinases to 72 well-defined kinase inhibitors. The authors observed that TG100-115 inhibited the purified kinase domain of human TRPM6 (Davis et al., 2011) . In line with these results, treatment of cells with TG100-115 blocked autophosphorylation of recombinant mouse TRPM6, suggesting that TG100-115 is able to suppress TRPM6 kinase activity in living cells . Another inhibitor of TRPM6 kinase was identified in a screen for organic compounds inducing mesoderm and definitive endoderm differentiation of human embryonic stem (hESC) cells (Geng & Feng, 2015) . This study suggested that a small molecule called mesendogen may inhibit TRPM6 kinase and thereby induce differentiation of hESC cells (Geng & Feng, 2015) .
TRPM6 in inherited hypomagnesemia in humans
Two laboratories independently discovered that loss-of-function mutations in the human TRPM6 gene give rise to a syndrome called primary hypomagnesemia type 1, intestinal (HOMG1) or hypomagnesemia with secondary hypocalcemia (HSH) (Schlingmann et al., 2005; Schlingmann et al., 2002; Walder et al., 2002) . Affected individuals (usually infants) present with generalized convulsions and muscle spasms. Clinical assessment at the time of manifestation usually reveals low serum levels of Mg 2+ (0.1-0.3 mM) and Ca 2+ (1-1.6 mM) as compared to healthy individuals (0.7-1.1 mM Mg 2+ and 2.2-2.9 mM Ca 2+ ). Hypomagnesemia and other symptoms are relieved after administration of high doses of Mg 2+ . Despite this treatment, serum Mg 2+ levels remain in the subnormal range (Konrad et al., 2004; Schlingmann et al., 2005; Schlingmann et al., 2007; Schlingmann et al., 2002; Walder et al., 2002) . HOMG1 can be regarded as a rare genetic syndrome since only few affected families often with a high degree of consanguinity have been identified so far (Altincik, Schlingmann, & Tosun, 2016; Apa et al., Fig. 3. Suggested model for V. Chubanov et al. Pharmacology and Therapeutics 184 (2018) 159-176 2008; Astor et al., 2015; Chen, Prasad, Kobrzynski, Campbell, & Filler, 2016; Chubanov et al., 2004; Coulter et al., 2015; Guran et al., 2012; Habeb, Al-Harbi, & Schlingmann, 2012; Horinouchi et al., 2017; Jalkanen et al., 2006; Katayama et al., 2015; Lainez et al., 2014; Li et al., 2016; Patel, Rayanagoudar, & Gelding, 2016; Schlingmann et al., 2005; Schlingmann et al., 2002; Walder et al., 2002; Zhao et al., 2013) . Many key aspects of HOMG1 are not well understood. For unknown reasons, several individuals homozygous for TRPM6 mutations were asymptomatic, while other patients showed normal serum Ca 2+ levels or displayed additional clinical symptoms such as mental retardation, osteoporosis, cardiac arrhythmia, severe failure to thrive and bilateral basal ganglia calcification (Altincik et al., 2016; Apa et al., 2008; Chubanov et al., 2004; Esteban-Oliva, Pintos-Morell, & Konrad, 2009; Guran et al., 2011; Habeb et al., 2012; Li et al., 2016; Schlingmann et al., 2005; Schlingmann et al., 2002; Walder et al., 2002; Zhao et al., 2013) , pointing to potential genetic heterogeneity of the disease (Chery et al., 1994; Li et al., 2016) . In line with this idea, a substantial predominance of male patients has been observed in several HOMG1 families (Chery et al., 1994) . Several explanations have been offered for the occurrence of hypocalcemia, including organ unresponsiveness to parathyroid hormone (PTH) and impaired formation of vitamin D3 (Konrad & Weber, 2003; Schlingmann et al., 2005; Woodard, Webster, & Carr, 1972) . Mechanistically, the etiology of hypomagnesemia in HOMG1 was discussed controversially. Initial clinical studies on HOMG1 patients suggested that Mg 2+ deficiency is caused by defective intestinal Mg 2+ uptake (Friedman, Hatcher, & Watson, 1967; Milla, Aggett, Wolff, & Harries, 1979) . More recently, it has been speculated that low Mg 2+ blood levels in HOMG1 individuals were primarily caused by a defect in Mg 2+ reabsorption in the DCT segment of the kidney (Schlingmann et al., 2005; Schlingmann et al., 2002; Walder et al., 2002) . However, compelling direct evidence for a 'DCT-centric' model has not been provided yet. Along these lines, the recent investigation of gene-modified mice globally lacking TRPM6 or specifically in the kidney or intestine pointed out that a defect in the intestinal Mg 2+ uptake is primarily responsible for organismal Mg 2+ deprivation (see the Section 3.6). Nevertheless, it is commonly accepted that HOMG1 is an autosomal recessive syndrome caused by loss-off-function mutations in TRPM6. The majority of HOMG1 alleles harbors stop and frame-shift mutations, or substitutions impairing exon splicing (Altincik et al., 2016; Apa et al., 2008; Astor et al., 2015; Chen et al., 2016; Chubanov et al., 2004; Guran et al., 2012; Habeb et al., 2012; Horinouchi et al., 2017; Jalkanen et al., 2006; Katayama et al., 2015; Lainez et al., 2014; Li et al., 2016; Patel et al., 2016; Schlingmann et al., 2005; Schlingmann et al., 2002; Walder et al., 2002; Zhao et al., 2013) . In addition, several point mutations in the protein coding sequence of TRPM6 have been found. Most of these missense mutations were identified within the cytosolic N-terminus of TRPM6 suggestive of a critical role of this domain for channel function. A remarkable example is the S141L variant. Upon heterologous expression, TRPM6 S141L was unable to associate with wild-type TRPM7 (Chubanov et al., 2004) . Consistently, introduction of the homologous mutation into TRPM7 (S138L) also affects channel assembly of TRPM7 (Chubanov et al., 2004) . Several missense mutations were located in the channel segment of TRPM6, invariably ablating TRPM6 function Lainez et al., 2014; Schlingmann et al., 2005) . A notable example is the P1017R variant in the pore-forming region of TRPM6 (Fig. 1B) . TRPM6 P1017R impairs channel activity of TRPM6/7
heteromers by dominant-negative suppression suggesting that a block of cation fluxes mediated by TRPM6/7 is sufficient for the development of HOMG1. A possible contribution of TRPM6 kinase activity to HOMG1 still remains elusive.
Genome-wide associations with the human TRPM6 gene
It has been suggested that Mg 2+ deficiency is associated with an increased risk of insulin resistance and type 2 diabetes (Sales & Pedrosa Lde, 2006; Takayanagi et al., 2015) . A recent screen for genome-wide associations revealed that two SNPs in TRPM6, rs3750425 and rs2274924, might confer susceptibility to type 2 diabetes in women with low Mg 2+ intake . Furthermore, these SNPs may be associated with a higher likelihood of developing gestational diabetes mellitus (Nair et al., 2012) . Genome-wide association studies iñ 15.000 individuals showed that the rs11144134 SNP in TRPM6 is associated with lower serum Mg 2+ levels (Meyer et al., 2010) . Genomewide association studies to correlate Mg 2+ intake with fasting glucose and insulin levels were conducted in~50.000 healthy Europeans (Hruby et al., 2013) . The authors reported that higher dietary Mg 2+ consumption was associated with reduced glucose and insulin concentrations, whereas rs2274924 in TRPM6 was associated with higher glucose levels. It has recently been shown that SNPs in human TRPM6 are associated with a neural tube closure defect, i.e. meningomyelocele (Sarac et al., 2016) . Hence, profiling of SNPs in TRPM6 may turn out as a useful new diagnostic indicator of insulin resistance and abnormalities of fetal development.
3.6. Lessons from TRPM6-deficient mice 3.6.1. Critical role of TRPM6 in prenatal development of mice Two independent studies characterized Trpm6-gene deficient mice. Walder et al. (Walder et al., 2009 ) generated mice with a frameshift mutation in Trpm6 due to deletion of the genomic sequence encompassing exons 5-7 of the gene, referred to here as the Trpm6 Δ5-7 allele.
Unexpectedly, the majority of mice homozygous for the Trpm6 Δ5-7 mutation died at e12.5 (Walder et al., 2009) . Few mutant mice that survived beyond e12.5, developed neural tube closure defects (NTD). Dietary Mg 2+ supplementation of pregnant females could not rescue the mortality of Trpm6 null embryos (Walder et al., 2009 ). The authors suggested that TRPM6 plays a direct role in neural tube closure resulting in embryonic mortality of mutants (Walder et al., 2009 et al., 2010) . Thus, the aforementioned mouse models carrying null mutations could not recapitulate the clinical symptoms of HOMG1 patients.
As an alternative recent approach, a set of new mouse lines carrying global or tissue-specific mutations in Trpm6 was generated and characterized to decipher the mechanisms responsible for the prenatal lethality of Trpm6-deficient mice (Chubanov et al., 2016) . In line with previous reports (Walder et al., 2009; Woudenberg-Vrenken, Sukinta, van der Kemp, Bindels, & Hoenderop, 2011) , Trpm6 βneo/+ mice were shown to be unable to produce viable Trpm6 βneo/βneo offspring (Chubanov et al., 2016) . Consequently, Trpm6 βneo/+ parent mice were used to determine the onset of the Trpm6 null embryonic lethality and the expression pattern of Trpm6 in the fetus at the respective developmental stage (Chubanov et al., 2016) . Trpm6 βneo/βneo embryos were present at e8.5-10.5, but were remarkably growth-delayed. Only few mutants were viable at e11.5-12.5, and no Trpm6 βneo/βneo individuals were found at e14.5. Unexpectedly, Trpm6 was not detectable in embryonic tissues in e8.5-12.5 embryos, but was present in extraembryonic cells within the developing placental labyrinth (Chubanov et al., 2016) . The placental labyrinth in mice comprises maternal sinusoids and fetal blood capillaries, separated by two layers of fetal trophoblast cells referred to as syncytiotrophoblast layer I (SynT-I) and Chubanov et al. Pharmacology and Therapeutics 184 (2018) 159-176 syncytiotrophoblast layer II (SynT-II) (Enders, 1965) . These syncytial layers mediate the exchange of metabolites and minerals between the maternal and fetal blood compartments (Simmons & Cross, 2005) . Interestingly, Trpm6 expression was restricted to SynT-I only (Chubanov et al., 2016 transport by the extraembryonic tissues (Chubanov et al., 2016) . Consequently, inactivation of Trpm6 would result in Mg 2+ deprivation and death of mutant embryos (Fig. 3) . In order to prove genetically that the lack of TRPM6 in extraembryonic cells underlies the lethality of Trpm6 null embryos, a mouse line carrying a "floxed" Trpm6 allele (Trpm6 fl ) with two LoxP sites flanking exon 17 of Trpm6 was generated. Exon 17 encodes the first transmembrane segment of TRPM6 and its excision by Cre recombinase entails a frame-shift mutation, further on referred to as the Trpm6
Δ17
allele (Chubanov et al., 2016) . Intercrosses of Trpm6 Δ17/+ mice did not yield viable Trpm6 Δ17/Δ17 pups indicating that Trpm6 Δ17 is a true null mutation (Chubanov et al., 2016) . The paternally inherited Sox2-Cre transgene triggers recombination only in epiblast cells (prior to Theiler stage 8), but not in extraembryonic cells including placental trophoblasts (Hayashi, Tenzen, & McMahon, 2003) . Therefore, Sox2-Cre is frequently used to study whether a gene is required in the embryo proper. This genetic strategy was employed to probe the role of TRPM6 in the fetus of Trpm6 fl/fl mice (Chubanov et al., 2016 (Chubanov et al., 2016) (Fig. 3) . It remains to be answered why, in contrast to Trpm6-deficient mice, human infants carrying HOMG1 mutations in TRPM6 are viable Schlingmann et al., 2002; Walder et al., 2002) . One answer to consider is that pioneering positional cloning studies (Schlingmann et al., 2002; Walder et al., 2002) and follow-up case reports Schlingmann et al., 2005) exclusively focused on hospitalized infants selected due to deleterious Mg 2+ deficiency, whereas other problems, such as infertility or embryonic death, might have been overlooked. Another explanation may rely on species differences between mice and humans, like the different morphology of the placental exchange interfaces, distinct fetal growth rates, litter sizes and dietary preferences (Simmons & Cross, 2005 (Chubanov et al., 2016) .
Of note,~50% of the body Mg 2+ content is stored in bones,~30% in muscle tissues and only~1% in serum (de Baaij et al., 2015) . ICP-MS analysis of Mg 2+ levels in serum, bones and gastrocnemius muscle confirmed that Trpm6-deficient mice develop a very severe systemic Mg 2+ deficit (Chubanov et al., 2016 transcripts were not detectable in the small intestine, but Trpm6-specific signals were observed in absorptive epithelial cells of the wild-type colon, but not in Trpm6-deficient tissues (Chubanov et al., 2016) . These findings corroborate the conclusion that the systemic Mg 2+ deficit in Trpm6-deficient mice is primarily caused by a defective Mg 2+ uptake in the colon (Chubanov et al., 2016) . Ksp-Cre (Shao, Somlo, & Igarashi, 2002) and Villin1-Cre (Madison et al., 2002 ) transgenic mice allow to specifically ablate floxed alleles in renal and intestinal epithelial cells, respectively. Ksp-Cre and Villin1-Cre were employed to further verify the contribution of the kidney versus intestine to the Trpm6 null phenotype (Chubanov et al., 2016 balance, whereas renal TRPM6 only plays a minor role in this regard (Chubanov et al., 2016) (Fig. 3) . (Chubanov et al., 2016) . Surprisingly, Trpm6 Δ17/Δ17 mice phenocopied salient pathologies reported for a set of mouse strains advocated as genetic models of 'accelerated' or 'premature' aging (Kujoth et al., 2005; Kuro-o et al., 1997; Lopez-Otin, Blasco, Partridge, Serrano, & Kroemer, 2013; Mostoslavsky et al., 2006; Niedernhofer et al., 2006; Trifunovic et al., 2004; van der Pluijm et al., 2007; Varela et al., 2005) . Thus, Trpm6-deficient mice displayed short lifespan, low physical activity, kyphosis, lung emphysema, sarcopenia and degeneration of lymphoid organs (Chubanov et al., 2016) . The GH/IGF1 signaling is a highly conserved aging-controlling pathway (Bartke, Sun, & Longo, 2013; Lopez-Otin et al., 2013) . Trpm6-deficient mice developed characteristic signs of a suppressed somatotropic GH/IGF1 axis including growth defect, decreased concentrations of serum IGF1 and of major urinary proteins (MUPs), reduced body temperature and increased insulin sensitivity (Chubanov et al., 2016) . It is well documented that naturally aged humans and mice show a gradual suppression of the GH/IGF1 axis Yuan et al., 2009) . Paradoxically, attenuation of the GH/IGF1 somatotropic axis is thought to contribute to lifespan extension in 'long-lived' mouse strains such as Ames (Prop1 df/df ), Snell (Pit1 dw/dw ), Ghr/bp −/− and Ghrhr lit/lit Boylston, DeFord, & Papaconstantinou, 2006; Schumacher, van der Pluijm, et al., 2008; Sonntag, Csiszar, deCabo, Ferrucci, & Ungvari, 2012; Steinbaugh, Sun, Bartke, & Miller, 2012) , also in animals subjected to caloric restriction or rapamycin treatment (Steinbaugh et al., 2012) . So far, the conundrum of a downmodulated GH/IGF1 axis both in long-lived and in progeroid mouse models has not been fully resolved yet. However, genome-wide transcriptome analyses of the aforementioned model organisms were interpreted to mean that suppression of the GH/IGF1 axis represents a defensive response aimed at slowing down growth and metabolism in favor of somatic preservation (Garinis et al., 2009; Lopez-Otin et al., 2013; Schumacher, Garinis, & Hoeijmakers, 2008; Schumacher, van der Pluijm, et al., 2008; Steinbaugh et al., 2012) . A characteristic hallmark of this process is the induction of common networks of genes harboring xenobiotic response elements (XRE) and antioxidant response elements (ARE), so-called 'longevity assurance genes' (Amador-Noguez et al., 2007; Boylston et al., 2006; Garinis et al., 2009; Schumacher, van der Pluijm, et al., 2008; Steinbaugh et al., 2012; . The elevation of blood bile acids acting via the farnesoid x receptor (FXR) was suggested as an upstream mechanism of XRE induction (Amador-Noguez et al., 2007; Jiang et al., 2013) , whereas the oxidative stress sensing complex Keap1/Nrf2 contributes to the induction of ARE containing genes (Steinbaugh et al., 2012; Sun V. Chubanov et al. Pharmacology and Therapeutics 184 (2018) 159-176 et al., 2013) . Remarkably, similar mechanisms are pertinent to Trpm6 null mice as well (Chubanov et al., 2016) . Thus, whole genome profiling of hepatic transcripts of Trpm6-deficient mice revealed a strong up-regulation of xenobiotic detoxification and antioxidant response genes controlled by XFR and Nrf2, respectively (Chubanov et al., 2016) . Furthermore, Trpm6-deficient mice showed increased blood levels of bile acids (Chubanov et al., 2016) and high levels of urinary 8-OH-dG (unpublished observations), a marker of oxidative DNA damage (Gan et al., 2012) , suggesting that bile acids and oxidative stress were likely upstream inducers of XFR and ARE networks in Trpm6-deficient mice (Chubanov et al., 2016) . Trpm6 null mice were characterized by profound lipodystrophy (Chubanov et al., 2016) , another common phenotype of progeroid (Barnhoorn et al., 2014; Hasty & Vijg, 2004; Kujoth et al., 2005; Kuro-o et al., 1997; Mostoslavsky et al., 2006; Niedernhofer et al., 2006; Trifunovic et al., 2004; Varela et al., 2005) and naturally aged mice (Bogue et al., 2014) . It has recently been shown that lipid metabolism is substantially changed during human aging (Houtkooper et al., 2011; Kim et al., 2014; Yu et al., 2012) . For instance, aged human cohorts displayed increased levels of sphingomyelins (SM), phosphatidylcholines (PC) and acylcarnitines (AC) (Yu et al., 2012) indicative of incomplete mitochondrial fatty acid oxidation, oxidative stress and altered cell membrane composition (Clement et al., 2009; Noland et al., 2009; Yu et al., 2012) . In line with these findings, a quantification of metabolites in the blood, liver and skeletal muscle of Trpm6-deficient mice revealed that circulating and tissue levels of several AC, SM and PC species with long-chain fatty acid residues were substantially altered (Chubanov et al., 2016) . Remarkably, a recently identified human aging marker, C18:1 acylcarnitine (Yu et al., 2012) , was one of two metabolites consistently up-regulated in all tissues examined in Trpm6-deficient mice (Chubanov et al., 2016) . As peripheral free carnitine concentrations were normal in Trpm6-deficient mice (Chubanov et al., 2016) , reduced activity of mitochondrial carnitine palmitoyltransferases (CPT) is a plausible explanation for the accumulation of long-chain AC species. This scenario is reminiscent of metabolic alterations seen in human patients afflicted with mutations in the CPT1 or CPT2 genes (Bonnefont et al., 2004) . The enzymatic activity of CPTs is tightly regulated by Mg 2+ and Mg·ATP (Pande, Lee, & Murthy, 1988; Saggerson, 1982) implying that CPTs may be preferentially affected by organismal Mg 2+ deficit. In line with such an idea, it was demonstrated that Mg 2+ is specifically required for the utilization of AC as an energy source in liver mitochondria isolated from wild-type mice (Chubanov et al., 2016) . Hence, insufficient mitochondrial utilization of AC represents a plausible mechanism contributing to catabolic metabolism displayed by Trpm6-deficient mice (Chubanov et al., 2016) . Notably, if Trpm6-deficient mice were fed with a high Mg 2+ diet, they were viable, exhibiting an unaltered morphology of internal organs and normal tissue contents of AC, indicating that the accelerated aging-like phenotypes in Trpm6-deficient mice were triggered by Mg 2+ deficiency (Chubanov et al., 2016) (Fig. 3) . Altogether, the metabolic 'fingerprint' of Trpm6-deficient mice mirrors many patterns observed in aged individuals. Oxidative stress, suppression of the GH/IGF1 axis and abnormal lipid metabolism may underlie the accelerating aging-like phenotypes of Trpm6-deficient mice (Chubanov et al., 2016) . Future experiments will have to show whether additional aging-associated processes have been triggered in Trpm6 null mice, for instance, inflammation and genomic and protein instability.
Assessment of high dietary Mg 2+ on the lifespan of mice
Investigations of Trpm6-deficient mice revealed that a sustained disruption of Mg 2+ homeostasis is detrimental for overall health and eventually reduces the lifespan of affected animals (Chubanov et al., 2016 ). This conclusion is concordant with recent studies showing that Mg 2+ metabolism may be linked to longevity. For instance, high dietary Mg 2+ supplementation of adult mice increased the number of hippocampal neural stem cells (Jia et al., 2016) , which, according to a recent study, appear to control organismal aging .
Other recent experiments showed that Mg 2+ acting alone or in conjunction with calorie restriction counteracted lifespan-shortening effects of RNA-DNA hybrid (R loop) accumulation in yeast and human cells (Abraham et al., 2016) . Therefore, the question was asked whether a Mg 2+ -enriched diet would exert a beneficial effect on the lifespan of wildtype mice. To this end, the effects of whole-life dietary Mg 2+ supplementation on the survival rate of the well-characterized longlived B6C3F1 mouse strain (Lipman, Dallal, & Bronson, 1999; Turturro et al., 1999) were examined (Chubanov et al., 2016) . Consistent with published reports Miller et al., 2011; Turturro et al., 1999) , the mean age of B6C3F1 females (886 days) was significantly extended (125%) by dietary restriction (DR) (Chubanov et al., 2016) . Notably, supplementation with three different Mg 2+ salts also significantly increased the mean age (~110%) (Chubanov et al., 2016) . Hence, opposite to TRPM6 dependent Mg 2+ deprivation, dietary Mg 2+ supplementation has a beneficial effect on the lifespan of mice (Chubanov et al., 2016) . Inadequate nutritional Mg 2+ intake is commonplace in Western societies (in up to 68% of the US population (King, Mainous, Geesey, & Woolson, 2005; Rosanoff, Weaver, & Rude, 2012) ). In addition, a growing percentage of the population is exposed to the growing number of drug-and alcohol-induced forms of hypomagnesemia (de Baaij et al., 2015) . Accordingly, it is reasonable to assume that such surprisingly common organismal Mg 2+ deficiency in humans elicits considerable negative effects on the health-and life-span in Western societies. Hence, large-scale investigations of nutritional Mg 2+ adjustments and their impact on lifespan of humans and different species should be enlightening in this regard.
Conclusions
In the past few years TRPM6 and TRPM7 have emerged as central gatekeepers of the organismal homeostasis of Mg 2+ and most likely other divalent cations as well. Recent experiments with cultured cells, gene-modified mouse models and clinical data obtained from patients carrying mutations in TRPM6 gene strongly support the notion that TRPM6 plays a pivotal role in the maintenance of organismal Mg 2+ balance. In addition, studies with Trpm6-gene deficient mice highlighted the important role of whole-body Mg 2+ homeostasis in the regulation of health-and life-span. However, further progress is needed to improve our understanding of TRPM7 function in living organisms. Yet, many enticing hypotheses recently put forward based on in vitro studies with the kinase domains of TRPM6 and TRPM7 await thorough examination in living animal models.
